211 related articles for article (PubMed ID: 22877998)
1. Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.
Frau R; Pillolla G; Bini V; Tambaro S; Devoto P; Bortolato M
Psychoneuroendocrinology; 2013 Apr; 38(4):542-51. PubMed ID: 22877998
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation.
Frau R; Bini V; Pes R; Pillolla G; Saba P; Devoto P; Bortolato M
Psychoneuroendocrinology; 2014 Jan; 39():204-213. PubMed ID: 24140269
[TBL] [Abstract][Full Text] [Related]
3. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.
Devoto P; Frau R; Bini V; Pillolla G; Saba P; Flore G; Corona M; Marrosu F; Bortolato M
Psychoneuroendocrinology; 2012 Oct; 37(10):1630-45. PubMed ID: 22029952
[TBL] [Abstract][Full Text] [Related]
5. Allopregnanolone is required for prepulse inhibition deficits induced by D
Mosher LJ; Cadeddu R; Yen S; Staudinger JL; Traccis F; Fowler SC; Maguire JL; Bortolato M
Psychoneuroendocrinology; 2019 Oct; 108():53-61. PubMed ID: 31228750
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.
Gresack JE; Seymour PA; Schmidt CJ; Risbrough VB
Psychopharmacology (Berl); 2014 May; 231(10):2189-97. PubMed ID: 24363077
[TBL] [Abstract][Full Text] [Related]
8. Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.
Frau R; Abbiati F; Bini V; Casti A; Caruso D; Devoto P; Bortolato M
Schizophr Res; 2015 Nov; 168(3):640-8. PubMed ID: 25999042
[TBL] [Abstract][Full Text] [Related]
9. Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.
Ces A; Reiss D; Walter O; Wichmann J; Prinssen EP; Kieffer BL; Ouagazzal AM
Neuropsychopharmacology; 2012 Jan; 37(2):378-89. PubMed ID: 21881568
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-like properties of 5-alpha-reductase inhibitors.
Bortolato M; Frau R; Orrù M; Bourov Y; Marrosu F; Mereu G; Devoto P; Gessa GL
Neuropsychopharmacology; 2008 Dec; 33(13):3146-56. PubMed ID: 18354385
[TBL] [Abstract][Full Text] [Related]
11. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
[TBL] [Abstract][Full Text] [Related]
12. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.
Weber M; Chang WL; Breier M; Ko D; Swerdlow NR
Behav Pharmacol; 2008 Dec; 19(8):786-95. PubMed ID: 19020413
[TBL] [Abstract][Full Text] [Related]
13. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
[TBL] [Abstract][Full Text] [Related]
14. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition.
Swerdlow NR; Shoemaker JM; Auerbach PP; Pitcher L; Goins J; Platten A
Psychopharmacology (Berl); 2004 Aug; 174(4):452-62. PubMed ID: 15300359
[TBL] [Abstract][Full Text] [Related]
15. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
16. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
Arnt J; Bøgesø KP; Hyttel J; Meier E
Pharmacol Toxicol; 1988 Mar; 62(3):121-30. PubMed ID: 3259694
[TBL] [Abstract][Full Text] [Related]
17. Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.
Wakabayashi C; Numakawa T; Ooshima Y; Hattori K; Kunugi H
Psychopharmacology (Berl); 2015 Dec; 232(24):4393-400. PubMed ID: 26359228
[TBL] [Abstract][Full Text] [Related]
18. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
Caine SB; Geyer MA; Swerdlow NR
Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
[TBL] [Abstract][Full Text] [Related]
19. Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.
Swerdlow NR; Martinez ZA; Hanlon FM; Platten A; Farid M; Auerbach P; Braff DL; Geyer MA
J Neurosci; 2000 Jun; 20(11):4325-36. PubMed ID: 10818168
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
